Valiant Laboratories Limited (VALIANTLAB.BO)
INR 127.0
(13.54%)
INR 127.0
(13.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -295.03 Million INR | -150.04% |
| 2022 | 589.55 Million INR | -3.34% |
| 2021 | 609.95 Million INR | 1930.03% |
| 2020 | -33.33 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | -295.03 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | -295.03 Million INR | -150.04% |
| 2023 Q2 | 607.08 Million INR | 0.0% |
| 2022 Q4 | 589.55 Million INR | 0.0% |
| 2022 FY | 589.55 Million INR | -3.34% |
| 2021 FY | 609.95 Million INR | 1930.03% |
| 2020 FY | -33.33 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | -954.9 Million INR | 69.103% |
| Amrutanjan Health Care Limited | -248.79 Million INR | -18.586% |
| Sigachi Industries Limited | 859.94 Million INR | 134.308% |
| Bal Pharma Limited | 1.26 Billion INR | 123.349% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 92.896% |
| Medico Remedies Limited | 78.67 Million INR | 474.991% |
| Lasa Supergenerics Limited | 205.79 Million INR | 243.359% |
| Venus Remedies Limited | -267.7 Million INR | -10.21% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 68.674% |
| Alpa Laboratories Limited | 35.36 Million INR | 934.296% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 104.792% |
| Shilpa Medicare Limited | 9.06 Billion INR | 103.253% |
| Aarti Drugs Limited | 5.54 Billion INR | 105.317% |
| Lupin Limited | 17.19 Billion INR | 101.716% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 107.988% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 107.542% |
| Windlas Biotech Limited | -273.04 Million INR | -8.054% |
| Suven Life Sciences Limited | -1.63 Billion INR | 81.93% |
| Eris Lifesciences Limited | 13.8 Billion INR | 102.137% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 110.458% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 102.942% |
| Ipca Laboratories Limited | 11.41 Billion INR | 102.585% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 74.517% |
| Achyut Healthcare Limited | -3.74 Million INR | -7775.921% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 99.593% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 108.943% |
| RPG Life Sciences Limited | -364.7 Million INR | 19.103% |
| Mankind Pharma Limited | -9.9 Billion INR | 97.022% |
| Laurus Labs Limited | 24.38 Billion INR | 101.21% |
| Piramal Pharma Limited | 42.27 Billion INR | 100.698% |
| Syncom Formulations (India) Limited | 46.21 Million INR | 738.445% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 100.927% |
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 107.632% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 93.115% |
| Unichem Laboratories Limited | 931.91 Million INR | 131.659% |
| Sequent Scientific Limited | 4.17 Billion INR | 107.06% |
| Novartis India Limited | -5.89 Billion INR | 94.992% |
| Wanbury Limited | 1.1 Billion INR | 126.679% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | 303.504% |
| Wockhardt Limited | 18.27 Billion INR | 101.615% |
| Themis Medicare Limited | 764.96 Million INR | 138.568% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 78.774% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 101.09% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 89.621% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 102.285% |
| Divi's Laboratories Limited | -39.77 Billion INR | 99.258% |
| NATCO Pharma Limited | -5.81 Billion INR | 94.928% |
| Gufic Biosciences Limited | 3.19 Billion INR | 109.236% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 73.211% |
| Ind-Swift Limited | 9.5 Billion INR | 103.103% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 87.435% |
| FDC Limited | -57.75 Million INR | -410.86% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 115.264% |
| Granules India Limited | 9.28 Billion INR | 103.177% |
| Medicamen Biotech Limited | 160.31 Million INR | 284.032% |
| Alkem Laboratories Limited | -1.6 Billion INR | 81.668% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 94.114% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | -1499.436% |
| Brooks Laboratories Limited | 49.48 Million INR | 696.205% |
| Megasoft Limited | 1.28 Billion INR | 122.95% |
| ZIM Laboratories Limited | 983.6 Million INR | 129.995% |
| Strides Pharma Science Limited | 23.25 Billion INR | 101.269% |
| Neuland Laboratories Limited | -214.05 Million INR | -37.828% |
| Morepen Laboratories Limited | -231.17 Million INR | -27.623% |
| Hikal Limited | 7.96 Billion INR | 103.703% |
| Indoco Remedies Limited | 6.47 Billion INR | 104.556% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 111.296% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | 345.78% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 130.235% |
| Hester Biosciences Limited | 2.29 Billion INR | 112.879% |